quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:18·793d
SECFiling
Icosavax Inc. logo

SEC Form EFFECT filed by Icosavax Inc.

ICVX· Icosavax Inc.
Health Care
Original source

Companies

  • ICVX
    Icosavax Inc.
    Health Care

Recent analyst ratings

  • Nov 17UpdateGuggenheim$28.00
  • Jan 4UpdateOppenheimer$27.00
  • Jun 29UpdateEvercore ISI$18.00
  • Mar 25UpdateEvercore ISI$10.00
  • Dec 29UpdateJefferies$50.00
  • Aug 23UpdateEvercore ISI Group$50.00

Related

  • PR581d
    Frazier Life Sciences Adds Industry Veteran and Serial Dealmaker, Adam Simpson, to Company Creation Team
  • PR765d
    CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)
  • SEC783d
    SEC Form 15-12G filed by Icosavax Inc.
  • 13D/G792d
    SEC Form SC 13D/A filed by Icosavax Inc. (Amendment)
  • 13D/G792d
    SEC Form SC 13D/A filed by Icosavax Inc. (Amendment)
  • SEC792d
    SEC Form SC TO-T/A filed by Icosavax Inc. (Amendment)
  • INSIDER793d
    SEC Form 4 filed by Ra Capital Management, L.P.
  • INSIDER793d
    Simpson Adam K. closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022